{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:07:19Z","timestamp":1792714039211,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.vaccine.2016.11.081","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T10:31:03Z","timestamp":1480588263000},"page":"231-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep"],"prefix":"10.1016","volume":"35","author":[{"given":"Piet A.","family":"van Rijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz J.","family":"Daus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke A.","family":"Maris-Veldhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Feenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 G.P.","family":"van Gennip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.081_b0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0147-9571(94)90044-2","article-title":"The epidemiology of bluetongue","volume":"17","author":"Gibbs","year":"1994","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.081_b0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrmicro1090","article-title":"Climate change and the recent emergence of bluetongue in Europe","volume":"3","author":"Purse","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.prevetmed.2009.11.007","article-title":"Financial consequences of the Dutch bluetongue serotype 8 epidemics of 2006 and 2007","volume":"93","author":"Velthuis","year":"2010","journal-title":"Prev Veter Med"},{"key":"10.1016\/j.vaccine.2016.11.081_b0020","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1412.080818","article-title":"Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland","volume":"14","author":"Hofmann","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.081_b0025","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3201\/eid1705.101742","article-title":"Novel bluetongue virus serotype from Kuwait","volume":"17","author":"Maan","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.081_b0030","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3201\/eid2012.140924","article-title":"Novel bluetongue virus in goats, Corsica, France, 2014","volume":"20","author":"Zientara","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.081_b0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0042-6822(89)90447-9","article-title":"Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype","volume":"170","author":"Mertens","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.11.081_b0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrmicro2052","article-title":"Prospects for improved bluetongue vaccines","volume":"7","author":"Roy","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0045","unstructured":"OIE. Terrestrial animal health code. Paris; 2014."},{"key":"10.1016\/j.vaccine.2016.11.081_b0050","first-page":"463","article-title":"Vaccination in the control of bluetongue in endemic regions: the South African experience","volume":"119","author":"Dungu","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2016.11.081_b0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vetmic.2010.04.020","article-title":"Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16","volume":"146","author":"Savini","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0060","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.vaccine.2009.10.107","article-title":"Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4","volume":"28","author":"Veronesi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.081_b0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/tbed.12004","article-title":"Bluetongue serotype 2 and 9 modified live vaccine viruses as causative agents of abortion in livestock: a retrospective analysis in Italy","volume":"61","author":"Savini","year":"2014","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2016.11.081_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cimid.2007.07.006","article-title":"Vaccines against bluetongue in Europe","volume":"31","author":"Savini","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.081_b0075","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1099\/vir.0.065615-0","article-title":"Bluetongue virus without NS3\/NS3a expression is not virulent and protects against virulent bluetongue virus challenge","volume":"95","author":"Feenstra","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0080","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1016\/j.vaccine.2014.10.033","article-title":"VP2-serotyped live-attenuated bluetongue virus without NS3\/NS3a expression provides serotype-specific protection and enables DIVA","volume":"32","author":"Feenstra","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.081_b0085","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1016\/j.vaccine.2015.09.020","article-title":"Development of a competitive ELISA for NS3 antibodies as DIVA test accompanying the novel Disabled Infectious Single Animal (DISA) vaccine for Bluetongue","volume":"33","author":"Tacken","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.081_b0090","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1016\/j.vaccine.2013.08.089","article-title":"Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: a genetic DIVA approach","volume":"31","author":"van Rijn","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.081_b0095","doi-asserted-by":"crossref","first-page":"e85788","DOI":"10.1371\/journal.pone.0085788","article-title":"Bluetongue virus nonstructural protein NS3\/NS3a is not essential for virus replication","volume":"9","author":"van Gennip","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.081_b0100","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1128\/JVI.00678-13","article-title":"NS3 of bluetongue virus interferes with the induction of type I interferon","volume":"87","author":"Chauveau","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0105","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1128\/JVI.01235-14","article-title":"Dual modulation of type I interferon response by bluetongue virus","volume":"88","author":"Doceul","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s13071-015-1063-3","article-title":"Non-structural protein NS3\/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis","volume":"8","author":"Feenstra","year":"2015","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2016.11.081_b0115","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.vaccine.2014.12.003","article-title":"Application of Bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2","volume":"33","author":"Feenstra","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.081_b0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF01314778","article-title":"Persistent infection of BHK21\/WI-2 cells with rubella virus and characterization of rubella variants","volume":"54","author":"Sato","year":"1977","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0125","doi-asserted-by":"crossref","first-page":"e30540","DOI":"10.1371\/journal.pone.0030540","article-title":"Rescue of recent virulent and avirulent field strains of bluetongue virus by reverse genetics","volume":"7","author":"van Gennip","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.081_b0130","doi-asserted-by":"crossref","first-page":"e92377","DOI":"10.1371\/journal.pone.0092377","article-title":"RNA elements in open reading frames of the bluetongue virus genome are essential for virus replication","volume":"9","author":"Feenstra","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.081_b0135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/vr.122.22.536","article-title":"Detection of antibodies against African swine fever virus using infected monolayers and monoclonal antibodies","volume":"122","author":"Wensvoort","year":"1988","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2016.11.081_b0140","doi-asserted-by":"crossref","first-page":"e44619","DOI":"10.1371\/journal.pone.0044619","article-title":"Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8","volume":"7","author":"van Gennip","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.081_b0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2006.11.007","article-title":"Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments","volume":"140","author":"Toussaint","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.11.081_b0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/1040638712440986","article-title":"Sustained high-throughput polymerase chain reaction diagnostics during the European epidemic of Bluetongue virus serotype 8","volume":"24","author":"van Rijn","year":"2012","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2016.11.081_b0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.vetmic.2016.07.013","article-title":"Experimental infection of small ruminants with bluetongue virus expressing Toggenburg Orbivirus proteins","volume":"192","author":"van Rijn","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0160","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1016\/j.vaccine.2010.06.034","article-title":"Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine","volume":"28","author":"Steinrigl","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.081_b0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/tbed.12100","article-title":"Bluetongue virus RNA detection by real-time rt-PCR in post-vaccination samples from cattle","volume":"62","author":"De Leeuw","year":"2015","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2016.11.081_b0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/vr.d1184","article-title":"Limitations of sandwich ELISAs for bluetongue virus antibody detection","volume":"168","author":"Eschbaumer","year":"2011","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2016.11.081_b0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vetmic.2012.01.022","article-title":"Bluetongue virus serotype 6 in Europe in 2008-Emergence and disappearance of an unexpected non-virulent BTV","volume":"158","author":"van Rijn","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1439-0450.2003.00682.x","article-title":"Studies on the safety and immunogenicity of the South African bluetongue virus serotype 2 monovalent vaccine: specific detection of the vaccine strain genome by RT-PCR","volume":"50","author":"Hammoumi","year":"2003","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.vaccine.2016.11.081_b0185","first-page":"11","article-title":"Stability study of bluetongue attenuated live vaccine serotype 2 after rehydration","volume":"39","author":"Ronchi","year":"2003","journal-title":"Vet Ital"},{"key":"10.1016\/j.vaccine.2016.11.081_b0190","unstructured":"Merial. Merial\u2019s bluetongue vaccine \u2013 information for veterinary professionals and farmers; 2015."},{"key":"10.1016\/j.vaccine.2016.11.081_b0195","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1128\/JVI.01514-13","article-title":"Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep","volume":"87","author":"Celma","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0200","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.1128\/JVI.05412-11","article-title":"Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge","volume":"85","author":"Matsuo","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.081_b0205","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1128\/JVI.02183-14","article-title":"A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus","volume":"88","author":"Nunes","year":"2014","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:22:52Z","timestamp":1759400572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16311537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0264410X16311537"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}